Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.492, 2005-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Long-acting risperidone cost saving in schizophrenia
Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. :
Access to resources
Recommend
Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. :
Long-acting risperidone adds value in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. :
Long-Acting Risperidone: A Review of Its Use in Schizophrenia
By Tracy Swainston Harrison Goa K.L.
CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. :